Global GMP Biologics 麻豆原创 Insights, Forecast to 2030

Publication ID:

PB512246394

Publication Date:

December 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

GMP Biologics refers to biopharmaceuticals produced following Good Manufacturing Practice (GMP) standards. These biologics, derived from living organisms, undergo strict quality control to ensure safety and efficacy in medical applications.
麻豆原创 Analysis and Insights: Global GMP Biologics 麻豆原创
The global GMP Biologics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for GMP Biologics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for GMP Biologics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for GMP Biologics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of GMP Biologics include Creative Diagnostics, Fisher Bioservices(Thermo Fisher Scientific), Polpharma Biologics, Intertek, HemaCare and AGC, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
GMP Biologics is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the GMP Biologics industry development. In 2023, global % revenue of GMP Biologics went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for GMP Biologics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of GMP Biologics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for GMP Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the GMP Biologics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global GMP Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for GMP Biologics revenue, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Creative Diagnostics
Fisher Bioservices(Thermo Fisher Scientific)
Polpharma Biologics
Intertek
HemaCare
AGC
Segment by Type
Recombinant Protein
Biosynthesized Hormones
Genetically Engineered Vaccines
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of GMP Biologics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Biologics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Biologics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global GMP Biologics 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Recombinant Protein
1.2.3 Biosynthesized Hormones
1.2.4 Genetically Engineered Vaccines
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global GMP Biologics 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Biologics 麻豆原创 Perspective (2019-2030)
2.2 Global GMP Biologics Growth Trends by Region
2.2.1 GMP Biologics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 GMP Biologics Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 GMP Biologics Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 GMP Biologics 麻豆原创 Dynamics
2.3.1 GMP Biologics Industry Trends
2.3.2 GMP Biologics 麻豆原创 Drivers
2.3.3 GMP Biologics 麻豆原创 Challenges
2.3.4 GMP Biologics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue GMP Biologics by Players
3.1.1 Global GMP Biologics Revenue by Players (2019-2024)
3.1.2 Global GMP Biologics Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global GMP Biologics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of GMP Biologics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global GMP Biologics 麻豆原创 Concentration Ratio
3.4.1 Global GMP Biologics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Biologics Revenue in 2023
3.5 Global Key Players of GMP Biologics Head office and Area Served
3.6 Global Key Players of GMP Biologics, Product and Application
3.7 Global Key Players of GMP Biologics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Biologics Breakdown Data by Type
4.1 Global GMP Biologics Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global GMP Biologics Forecasted 麻豆原创 Size by Type (2025-2030)
5 GMP Biologics Breakdown Data by Application
5.1 Global GMP Biologics Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global GMP Biologics Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America GMP Biologics 麻豆原创 Size (2019-2030)
6.2 North America GMP Biologics 麻豆原创 Size by Type
6.2.1 North America GMP Biologics 麻豆原创 Size by Type (2019-2024)
6.2.2 North America GMP Biologics 麻豆原创 Size by Type (2025-2030)
6.2.3 North America GMP Biologics 麻豆原创 Share by Type (2019-2030)
6.3 North America GMP Biologics 麻豆原创 Size by Application
6.3.1 North America GMP Biologics 麻豆原创 Size by Application (2019-2024)
6.3.2 North America GMP Biologics 麻豆原创 Size by Application (2025-2030)
6.3.3 North America GMP Biologics 麻豆原创 Share by Application (2019-2030)
6.4 North America GMP Biologics 麻豆原创 Size by Country
6.4.1 North America GMP Biologics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America GMP Biologics 麻豆原创 Size by Country (2019-2024)
6.4.3 North America GMP Biologics 麻豆原创 Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe GMP Biologics 麻豆原创 Size (2019-2030)
7.2 Europe GMP Biologics 麻豆原创 Size by Type
7.2.1 Europe GMP Biologics 麻豆原创 Size by Type (2019-2024)
7.2.2 Europe GMP Biologics 麻豆原创 Size by Type (2025-2030)
7.2.3 Europe GMP Biologics 麻豆原创 Share by Type (2019-2030)
7.3 Europe GMP Biologics 麻豆原创 Size by Application
7.3.1 Europe GMP Biologics 麻豆原创 Size by Application (2019-2024)
7.3.2 Europe GMP Biologics 麻豆原创 Size by Application (2025-2030)
7.3.3 Europe GMP Biologics 麻豆原创 Share by Application (2019-2030)
7.4 Europe GMP Biologics 麻豆原创 Size by Country
7.4.1 Europe GMP Biologics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe GMP Biologics 麻豆原创 Size by Country (2019-2024)
7.4.3 Europe GMP Biologics 麻豆原创 Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China GMP Biologics 麻豆原创 Size (2019-2030)
8.2 China GMP Biologics 麻豆原创 Size by Type
8.2.1 China GMP Biologics 麻豆原创 Size by Type (2019-2024)
8.2.2 China GMP Biologics 麻豆原创 Size by Type (2025-2030)
8.2.3 China GMP Biologics 麻豆原创 Share by Type (2019-2030)
8.3 China GMP Biologics 麻豆原创 Size by Application
8.3.1 China GMP Biologics 麻豆原创 Size by Application (2019-2024)
8.3.2 China GMP Biologics 麻豆原创 Size by Application (2025-2030)
8.3.3 China GMP Biologics 麻豆原创 Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia GMP Biologics 麻豆原创 Size (2019-2030)
9.2 Asia GMP Biologics 麻豆原创 Size by Type
9.2.1 Asia GMP Biologics 麻豆原创 Size by Type (2019-2024)
9.2.2 Asia GMP Biologics 麻豆原创 Size by Type (2025-2030)
9.2.3 Asia GMP Biologics 麻豆原创 Share by Type (2019-2030)
9.3 Asia GMP Biologics 麻豆原创 Size by Application
9.3.1 Asia GMP Biologics 麻豆原创 Size by Application (2019-2024)
9.3.2 Asia GMP Biologics 麻豆原创 Size by Application (2025-2030)
9.3.3 Asia GMP Biologics 麻豆原创 Share by Application (2019-2030)
9.4 Asia GMP Biologics 麻豆原创 Size by Region
9.4.1 Asia GMP Biologics 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia GMP Biologics 麻豆原创 Size by Region (2019-2024)
9.4.3 Asia GMP Biologics 麻豆原创 Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size (2019-2030)
10.2 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America GMP Biologics 麻豆原创 Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Creative Diagnostics
11.1.1 Creative Diagnostics Company Details
11.1.2 Creative Diagnostics Business Overview
11.1.3 Creative Diagnostics GMP Biologics Introduction
11.1.4 Creative Diagnostics Revenue in GMP Biologics Business (2019-2024)
11.1.5 Creative Diagnostics Recent Developments
11.2 Fisher Bioservices(Thermo Fisher Scientific)
11.2.1 Fisher Bioservices(Thermo Fisher Scientific) Company Details
11.2.2 Fisher Bioservices(Thermo Fisher Scientific) Business Overview
11.2.3 Fisher Bioservices(Thermo Fisher Scientific) GMP Biologics Introduction
11.2.4 Fisher Bioservices(Thermo Fisher Scientific) Revenue in GMP Biologics Business (2019-2024)
11.2.5 Fisher Bioservices(Thermo Fisher Scientific) Recent Developments
11.3 Polpharma Biologics
11.3.1 Polpharma Biologics Company Details
11.3.2 Polpharma Biologics Business Overview
11.3.3 Polpharma Biologics GMP Biologics Introduction
11.3.4 Polpharma Biologics Revenue in GMP Biologics Business (2019-2024)
11.3.5 Polpharma Biologics Recent Developments
11.4 Intertek
11.4.1 Intertek Company Details
11.4.2 Intertek Business Overview
11.4.3 Intertek GMP Biologics Introduction
11.4.4 Intertek Revenue in GMP Biologics Business (2019-2024)
11.4.5 Intertek Recent Developments
11.5 HemaCare
11.5.1 HemaCare Company Details
11.5.2 HemaCare Business Overview
11.5.3 HemaCare GMP Biologics Introduction
11.5.4 HemaCare Revenue in GMP Biologics Business (2019-2024)
11.5.5 HemaCare Recent Developments
11.6 AGC
11.6.1 AGC Company Details
11.6.2 AGC Business Overview
11.6.3 AGC GMP Biologics Introduction
11.6.4 AGC Revenue in GMP Biologics Business (2019-2024)
11.6.5 AGC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Creative Diagnostics
Fisher Bioservices(Thermo Fisher Scientific)
Polpharma Biologics
Intertek
HemaCare
AGC

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.